Christian Dior : Dividende 2024
Paris, le 18 avril 2025 DIVIDENDE 2024 L’Assemblée Générale de Christian Dior, réunie le jeudi 17 avril 2025, a approuvé au titre de l’exercice 2024 le paiement d’un dividende de…
Producers Online
Finding producers online involves identifying the right platforms, networks, and resources where producers showcase their work or are actively seeking projects. Here are some effective strategies:
When reaching out to producers, be clear about your project needs, budget, and timelines. This helps in finding the right match quickly
Paris, le 18 avril 2025 DIVIDENDE 2024 L’Assemblée Générale de Christian Dior, réunie le jeudi 17 avril 2025, a approuvé au titre de l’exercice 2024 le paiement d’un dividende de…
Approval based on Phase 3 trials demonstrating Dupixent significantly reduced itch and hives compared to placebo In the U.S., there are more than 300,000 adults and adolescents aged 12 years…
BOLLORÉ COMMUNIQUÉ DE PRESSE Le 17 avril 2025 Bolloré SE avait déposé le 13 septembre 2024 trois offres publiques de retrait alternatives suivies d’un retrait obligatoire visant les actions de…
BOLLORÉ PRESS RELEASE April 17, 2025 On September 13, 2024, Bolloré SE had filed three alternative buyout offers followed by mandatory squeeze-outs on the shares of Compagnie du Cambodge, Financière…
Dupixent approved in the US as the first new targeted therapy in over a decade for chronic spontaneous urticaria Approval based on phase 3 studies demonstrating Dupixent significantly reduced itch…
Le Dupixent devient le premier nouveau médicament ciblé approuvé aux États-Unis depuis plus de dix ans pour le traitement de l’urticaire chronique spontanée Aux États-Unis, le Dupixent est indiqué à…
ERRATUM – ANNULE ET REMPLACE Nous regrettons une erreur dans le tableau inclus dans le communiqué de presse en français. Merci de le remplacer par celui-ci. Croissance des ventes de…
CHICAGO, April 16, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R&D, owner of proprietary…
The agreement would facilitate providing Tevogen Bio with in-house cell therapy production capabilitiesFormalized agreement aligns with previously announced topline forecasts WARREN, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio…
RESTON, VA, April 16, 2025 (GLOBE NEWSWIRE) -- Stride Inc. (NYSE: LRN) announced today it plans to discuss its third quarter fiscal year 2025 financial results during a conference call…